Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-276879

Chief Legal Officer acquired 62,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-22 Grant or award : show line 1 in the form +62,500 333,579 D
Loading xslF345X06/ownership.xml…